Easton Launches www.EcigMarkets.com Ahead of Schedule and Commences Distributorship of Snoop Dog's Product Lines

TORONTO, ON--(Marketwired - Oct 31, 2014) - Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has launched www.ecigmarkets.com ahead of schedule and commences distributorship of Snoop Dog's product lines.

On October 7th Easton Pharmaceuticals announced its entry into the Vaporizer, Glassware and E Liquid sector as a complement to its Medical Marijuana initiatives.

On October 22 Easton hired Toronto based Digitalshock Media http://tiefactory.info/ for Development and launch of its vaporizer initiatives and associated SEO and web marketing campaign for all product lines. Digital Shock's other clients include Disney, Coca Cola, Tylenol, Wind Mobile, SEGA and Gameloft. A two week timeline was allotted for website completion.

Today Easton is pleased to announce it has completed its outlined project ahead of original timeline estimates.

Digital Shock CEO, Mr. Thanhda Tie stated, "I'm happy to have completed the website launch ahead of the Christmas shopping season and ahead of the prior stated completion timeline of 2 weeks. We are looking forward to providing our expertise in this sector and to assist Easton in developing a new successful business."

Snoop Dogg, a well-known American rapper and actor has sold over 30 million albums worldwide. His music career began in 1992 when he was discovered by Dr. Dre. He collaborated on Dre's solo debut The Chronic (1992), and on the theme song to the feature film Deep Cover. He is well known and recognized for his advocacy for Medicinal Marijuana legalization.

Easton has acquired a 100% ownership in websites http://www.EcigMarkets.com as well as http://www.420andfriends.com/, its internet business, including its wholesale segments. Easton plans to carry not only their exclusive branded products, celebrity endorsed product lines, but market and distribute premium products.

Easton Pharmaceuticals CEO Carla Pepe commented, "We are committed to speeding up our current product time-lines which has been demonstrated with a fully functional launch in under three weeks from our initial announcement. Our current focus is on gathering and maintaining a confidential patient population database who have current medical marijuana needs. We believe this will be a great value add for our current partners and gives us a head start when we are granted a MMPR License or partner up with a current MMPR Licensed Provider."